Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1185 of 5804
-
New sleep drug could help those battling opioid addiction
Symptom relief Recruiting nowPeople with opioid use disorder (OUD) can have trouble falling or staying asleep. Researchers want to know if suvorexant will help people with OUD fall asleep and stay asleep. The goal of this study is to learn about the safety of suvorexant and how well people tolerate it. Resea…
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Glow-in-the-Dark dye could help breast cancer patients avoid second surgery
Disease control TerminatedTo learn if Pegulicianine Fluorescence-Guided Surgery (pFGS), which is part of the Lumicell Direct Visualization System, and Digital Breast Tomosynthesis (DBT) can improve the identification of tumor margins during a partial mastectomy and decrease the need for a second surgery.
Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New radiation technique aims to cut side effects for pelvic cancer patients
Symptom relief Recruiting nowPelvis Adaptive radiotherapy (ART) is a two phase study looking at using adaptive radiotherapy to help reduce toxicity for cancer patients having radiotherapy in the pelvic region. Adaptive radiotherapy is a new technology that provides the ability to account for daily changes i…
Phase: NA • Sponsor: Royal North Shore Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
New 'Go-Slow' drug combo aims to help frailest myeloma patients
Disease control Recruiting nowHistorically, the frailest patients with multiple myeloma are under-represented in clinical trials, and have very high rates of treatment discontinuation, and early treatment mortality. The investigators hypothesize that a go-slow gentle approach to starting treatment in such pat…
Phase: PHASE2 • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New drug DS3610a enters first human tests for Hard-to-Treat cancers
Disease control Recruiting nowThis study is designed to assess the safety, tolerability, and efficacy of DS3610a, given as a single agent to participants with advanced or metastatic solid tumors.
Phase: PHASE1 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
One-Shot hope for blinding eye disease? new trial underway
Disease control Recruiting nowThis is a sequential Phase 1/2, two-part, multicenter study on safety, tolerability, and efficacy of one-time intravitreal SAR446597 for the treatment of participants with Geographic Atrophy (GA) secondary to Age-related Macular Degeneration (AMD). The core phase duration will b…
Phase: PHASE1, PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
68,000 patients join study to see if tackling racism in clinics improves chronic disease outcomes
Disease control Recruiting nowThe goal of this clinical trial is to learn if the implementation of the WE CARE social determinants of health (SDOH) screening and referral intervention with an antiracist lens in primary care settings can lead to a meaningful decrease in chronic disease by monitoring conditions…
Phase: NA • Sponsor: University of Massachusetts, Worcester • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New hope for tough lung cancer: ALPS12 drug trial begins
Disease control Recruiting nowThis study is a phase I, open-label, multicenter trial designed to evaluate the safety, tolerability, pharmacokinetics, immunogenicity, and antitumor activity of ALPS12 in patients with extensive-stage small cell lung cancer. The study consists of two parts: a dose-escalation par…
Phase: PHASE1 • Sponsor: Chugai Pharmaceutical • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
AI could catch deadly wasting syndrome early in pancreatic cancer patients
Knowledge-focused Recruiting nowThis observational study aims to (1) validate a multimodal artificial intelligence (AI) model for early detection of cancer-associated cachexia in pancreatic cancer patients and (2) assess the feasibility and acceptability of diet and exercise interventions for cachexia managemen…
Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Zap to walk: brain and spine stimulation may boost Parkinson's rehab
Symptom relief Recruiting nowThe trial will include 51 adult participants with Parkinson's disease and postural instability and gait disorders (PD-PIGD) and 20 age- and sex-matched healthy controls. At baseline (T0) patients will undergo neurological and cognitive/behavioural assessments, gait/balance evalu…
Phase: NA • Sponsor: IRCCS San Raffaele • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Simple blood test may spot lung cancer earlier
Diagnosis Recruiting nowThis research is a clinical performance study of in vitro diagnostic device (IVD), a prospective, multicentre, open-label, case-control clinical investigation aimed at constructing a predictive model that allows results to be classified as positive or negative in relation to the …
Phase: NA • Sponsor: Grupo Español de Investigación en Diagnóstico y Tratamiento Hipertemprano de Enfermedades (GeDiTPhe) • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC
-
Could a simple polyp removal plus a drug replace major sinus surgery?
Disease control Not yet recruitingThis study compares two surgical approaches combined with anti-IL-5 therapy in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). Patients will be randomly assigned to one of the three groups: (1) anti-IL-5 alone, (2) anti-IL-5 with simple polyp removal, or (3) anti…
Phase: PHASE4 • Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New hope for arthritis sufferers? drug tulisokibart put to the test
Disease control OngoingResearchers are looking for new ways to treat rheumatoid arthritis (RA). Methotrexate (MTX) is a standard (usual) treatment for RA. However, MTX and other current treatments may not work well to treat RA symptoms for many people. This study will help find out if a study medicine…
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Sound waves aimed at the brain could ease Parkinson's symptoms
Symptom relief Recruiting nowThis is a pilot randomized, sham-controlled, double-blind, multi-center study evaluating the safety and preliminary effectiveness of the Gen0Bh Transcranial Focused Ultrasound System for the treatment of motor symptoms in individuals with idiopathic Parkinson's disease.
Phase: NA • Sponsor: Sanmai Technologies PBC dba Sanmai • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Can a smartphone app curb suicide risk in college students?
Disease control ENROLLING_BY_INVITATIONMobile-based applications, such as JasprHealth, can deliver evidence-based skills intended to reduce imminent suicide risk (e.g., reducing means access), improve emotional states (e.g., via distraction and coaching to act opposite to emotions), and reduce feelings of social isola…
Phase: NA • Sponsor: University of Massachusetts, Amherst • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Could a simple mineral ease severe asthma attacks in kids?
Symptom relief Recruiting nowDespite optimal initial emergency department (ED) therapy, 50% of children with severe acute asthma have ongoing moderate-severe respiratory distress. Guidelines recommend intravenous magnesium (IVMg) for them, yet evidence for IVMg efficacy is scant and disparate. While early sm…
Phase: PHASE3 • Sponsor: Suzanne Schuh • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Exercise from home fights cancer fatigue in rural patients
Symptom relief Recruiting nowThis study investigates the efficacy of a telehealth exercise program designed specifically for rural cancer survivors with cancer-related fatigue (CRF). Small dried blood samples and measures of physical function will be collected throughout the program. The main questions it ai…
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
New device aims to seal dangerous brain aneurysms
Disease control Not yet recruitingUsing data obtained from the treatment of intracranial non-saccular aneurysms with flow diverter, evaluate the effecy and safety of blood flow diverter for the endovascular treatment of intracranial non-saccular aneurysms.
Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Mini implant aims to lower eye pressure during cataract surgery
Disease control Recruiting nowTo evaluate the efficacy and safety of istent inject W in reducing intraocular pressure in Chinese adult patients with open-angle glaucoma complicated with cataract.
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New study aims to help cancer survivors ditch opioids for good
Symptom relief Recruiting nowThis proposal is relevant to the 240,000 cancer survivors who continue to use opioids long after they have successfully completed treatment for cancer at the VHA, placing them at risk of opioid addiction and overdose, and other opioid-related problems. Yet, there are no programs …
Phase: PHASE4 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC